Serum levels of infliximab and adalimumab are associated with deep remission in inflammatory bowel disease

Autor: Pascual-Marmaneu, Óscar *, Belles-Medall, María D., Ferrando-Piqueres, Raúl, Almela-Notari, Pedro, Mendoza-Aguilera, María, Álvarez-Martín, Tamara
Zdroj: In Farmacia Hospitalaria September-October 2021 45(5):225-233
Databáze: ScienceDirect